Desmoid Tumor Mimicking GIST Recurrence

被引:2
作者
Nandy N. [1 ,4 ]
Garvin W. [2 ]
Mesologites T.L. [3 ]
Silver J.S. [2 ]
Dasanu C.A. [2 ]
机构
[1] Department of Internal Medicine, University of Connecticut, Farmington, CT
[2] Department of Hematology-Oncology, Medical Oncology and Blood Disorders, Saint Francis Hospital and Medical Center, Hartford, CT
[3] Department of Pathology, Saint Francis Hospital and Medical Center, Hartford, CT
[4] 100 Wells Street Apt #903, Hartford, 06103, CT
关键词
Imatinib; Familial Adenomatous Polyposis; Gastrointestinal Stromal Tumor; Imatinib Mesylate; Desmoid Tumor;
D O I
10.1007/s12029-014-9592-0
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:125 / 128
页数:3
相关论文
共 21 条
  • [1] Dumont A.G., Rink L., Godwin A.K., Et al., A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients, Ann Oncol, 23, 5, pp. 1335-1340, (2012)
  • [2] Kindbloom L.G., Remotti H.E., Aldenborg, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal, Am J Pathol, 152, pp. 1259-1269, (1998)
  • [3] Hirota S., Isozaki K., Moriyama Y., Et al., Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors, Science, 279, pp. 577-580, (1998)
  • [4] Demetri G.D., von Mehren M., Blanke C.D., Et al., Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors, N. Engl. J. Med, 347, pp. 472-480, (2002)
  • [5] Heinrich M.C., Corless C.L., Demetri G.D., Et al., Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor, J Clin Oncol, 21, pp. 4342-4349, (2003)
  • [6] Verweij J., Casali P.G., Zalcberg J., Et al., Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomized trial, Lancet, 364, pp. 1127-1134, (2004)
  • [7] Blanke C.D., Demetri G.D., von Mehren M., Et al., Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patinets with unresectable or metastatic gastrointestinal stromal tumors expressing KIT, J Clin Oncol, 26, pp. 620-625, (2008)
  • [8] Miettinen M., Fetsch J.F., Sobin L.H., Et al., Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases, Am J Surg Pathol, 30, pp. 90-96, (2006)
  • [9] Carney J.A., Sheps S.G., Go V.L., Et al., The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma, N Engl J Med, 296, pp. 1517-1518, (1977)
  • [10] O'Riain C., Corless C.L., Heinrich M.C., Et al., Gastrointestinal stromal tumors: insights from a new familial GIST kindred with unusual genetic and pathologic features, Am J Surg Pathol, 29, pp. 1680-1683, (2005)